Eway, Rey S.
HRN: 29-46-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/09/2026
MUPIROCIN 2%, 15G (TUBE)
08/09/2026
08/15/2026
TOPICAL
15g
BID
Lacerated Wound
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: